Moreover, a recent study has demonstrated that combination of carboplatin with either everolimus (mTOR inhibitor) or trametinib (ERK inhibitor) decreased cellular proliferation of astrocytoma cells [104]. This evidence concerns the gene MTOR and astrocytoma (excluding glioblastoma).